Malignant Spinal Cord Compression: Management

Malignant Spinal Cord Compression: overview

This algorithm covers malignant spinal cord compression, an oncologic emergency in which neurologic function at the time of treatment largely determines the outcome. It should be suspected in any patient with cancer and new back pain or neurologic symptoms.

Dexamethasone is started immediately when there is a deficit or high suspicion, commonly 10 mg intravenously and then 16 mg daily, without waiting for imaging. Whole-spine MRI with contrast is obtained within 24 hours (CT myelography if MRI is not possible). Patients with spinal instability, a single level of compression and a reasonable prognosis are offered decompressive surgery followed by radiation, supported by the Patchell trial, which showed better ambulation than radiation alone. Radiosensitive tumors such as myeloma, lymphoma and small cell lung cancer are treated with radiation, plus systemic therapy when the tumor is chemosensitive. Patients who are not surgical candidates receive radiation alone, with 8 Gy in one fraction or 20 Gy in five fractions (SCORAD III) favored for those with a poor prognosis. The NOMS framework and the SINS score help decide between surgery and radiation.

Trials behind this algorithm

Patchell ESCC Surgery Trial Patchell RA et al, Lancet, 2005; PMID: 16112300

Background reading: Supportive care board review notes.

Malignant Spinal Cord Compression: the algorithm in words

Steroids, urgent MRI, then surgery or radiation. Starting point: Cancer + back pain or neurologic deficit: suspect MSCC. Full background: Supportive care notes.

Immediately (first-line): Do not wait: Dexamethasone 10 mg IV, then 16 mg/day (if deficit or high suspicion).
Imaging (first-line): Within 24 h: Whole-spine MRI with contrast (CT myelogram if MRI not possible).
Surgical candidate (first-line): Surgery then RT: Decompressive surgery + postop RT (Patchell (better ambulation)).
Radiosensitive tumor (first-line): Myeloma, lymphoma, SCLC: Radiation therapy (plus systemic therapy if chemosensitive).
Not a surgical candidate (first-line): Radiation alone: 8 Gy x 1 or 20 Gy in 5 fractions (SCORAD III; poor prognosis).

Simplified board-prep scaffold; verify against current guidelines. Ambulatory status at diagnosis is the strongest predictor of outcome, so treat on suspicion. Use the NOMS framework (neurologic, oncologic, mechanical, systemic) and the SINS score for stability. Dexamethasone 10 mg IV load then 16 mg daily is common; high-dose regimens add toxicity without clear benefit.